
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Stedman's Plus Version 2012 Medical/Pharmaceutical Spellchecker contains nearly 500,000 medical, pharmaceutical, and bioscience terms to ensure users the most current, comprehensive, and reliable content on the market. Compatible with a broad range of word processing systems, the Spellchecker is convenient for every user who creates or edits medical documentation. The standard single-user version is available as a Windows and Macintosh compatible CD-ROM or as a downloadable file via the Stedmans.com or LWW.com websites. The 2012 version includes new medical and equipment terms introduced in 2011 and updated drug terminology drawn from Facts & Comparisons' American Drug Index 2012.
The 2012 upgrade of Stedman's Plus Medical/Pharmaceutical Spellchecker provides an extensive lexicon for medical documentation. This software upgrade contains nearly 500,000 medical, pharmaceutical, and bioscience terms, ensuring users have access to current and comprehensive content. It is compatible with a wide range of word processing systems, making it a valuable tool for anyone creating or editing medical documentation. The 2012 version specifically incorporates new medical and equipment terms from 2011 and updated drug terminology from the American Drug Index 2012.
As an upgrade to a well-established medical spellchecker, Stedman's Plus Version 2012 is expected to be a reliable tool for professionals requiring accuracy in medical documentation. Its strength lies in its extensive database, which is regularly updated to reflect the latest terminology. The inclusion of terms from 2011 and the American Drug Index 2012 ensures its continued relevance for users in the medical and pharmaceutical fields. Its broad compatibility further solidifies its utility across various word processing platforms.
Page Count:
0
Publication Date:
2012-02-24
Publisher:
Lippincott Williams & Wilkins
ISBN-10:
145114671X
ISBN-13:
9781451146714
No comments yet. Be the first to share your thoughts!